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Soybean protein has been proposed for distinct applications within nutritional, pharmaceutical, and cosmetic in-
dustries among others. More recently, soy-based biomaterials have also demonstrated promising properties for
biomedical applications. However, althoughmany reportswithin other fields exist, the inflammatory/immunogenic
potential of those materials is still poorly understood and therefore can hardly be controlled. On the contrary,
chitosan (Cht) has been well explored in the biomedical field, either by itself or combined with synthetic or other
natural-based polymers. Therefore, the combination of chitosan with soybean protein is foreseen as a suitable
approach to control the biological behavior of soy-based biomaterials. Under this context this work was designed to
try to understand the influence of chitosan in the host response elicited by soy-based biomaterials. Soybean protein
isolate powder (SI-P) and Cht powder (Cht-P) were injected as suspension into the intraperitoneal cavity of rats. SI-P
induced the recruitment of higher numbers of leukocytes compared to the Cht-P during the entire observation
period. In this sense, SI-P elicited a considerable reaction from the host comparing to the Cht-P, which elicited
leukocyte recruitment similar to the negative control. After subcutaneous implantation of the soybean anddenatured
membranes, (SI-M and dSI-M) a severe host inflammatory reaction was observed. Conversely, Cht/soy-based
membranes (Cht/soy-based membranes) showed the induction of a normal host response after subcutaneous im-
plantation in rats, which allowed concluding that the addition of chitosan to the soy-based membranes improved
their in vivo performance. Thus, the presented results assert the improvement of the host response, considering
inflammatory cells recruitment, and overall inflammatory reaction, when chitosan is combined to soybean. Together
with previous results that reported their promising physicochemical characteristics and their inability to activate
human polymorphonuclear neutrophils in vitro, the herein presented conclusions reinforce the usefulness of theCht/
soy-based membranes and justify the pursue for a specific application within the biomedical field.
Introduction
Soybean protein biomaterials have demonstrated quiteinteresting properties for bone regeneration purposes1–5;
nonetheless, few studies6–8 have in fact investigated their
suitability within the field. Santin et al.9 showed that soy-
bean-based biomaterials promote osteoblast-like cells’ dif-
ferentiation in vitro without inducing activation of human
macrophages (MØ).9 However, additional studies are re-
quired to further elucidate the potential of these materials in
the biomedical field. Moreover, despite the wide use of soy
products in nutritional, pharmaceutical, cosmetic, and many
other industries,10 numerous allergic reactions, from skin,
gastrointestinal and respiratory tract up to anaphylaxis,10,11
have been attributed to the soy Gly m 4 protein, homologous
of the major birch pollen allergen, Bet v 1.11
In contrast to soybean protein, chitosan has been exten-
sively proposed in the biomedical arena for bone-,12–16
cartilage-,13,17,18 and skin-related13,19,20 applications. The
promotion of osteoblast proliferation and activity character-
ized by upregulated expression of bone-related proteins and
mineral-rich matrix deposition, directed by chitosan-based
structures, has been well demonstrated.15,16 Concerning
cartilage-related applications, the structural similarity of
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chitosan with various glycosaminoglycans found in articular
cartilage has burst the investigations. Besides playing a role
in modulating chondrocyte morphology, differentiation, and
function,18 chitosan was shown to act on the growth of
epiphyseal cartilage and wound healing of articular carti-
lage.17 The successful role of chitosan in the skin-wound-
healing mechanisms has been confirmed.19–21 Although it
was observed that chitosan does not directly accelerate ex-
tracellular matrix production by fibroblast-like cells,22 it was
proven that chitosan-based materials have the capacity to
promote the production of growth factors, such as trans-
forming growth factors-b1 and platelet-derived growth fac-
tor by MØ21 which, in turn, induce and/or enhance
extracellular matrix production.20,21 Moreover, these mate-
rials accelerate the infiltration of polymorphonuclear neu-
trophils (PMNs) at the early stage of wound healing that is
followed by the production of collagen by fibroblasts.19
Despite all the promising results in the use of Cht for the
biomedical field, studies from different groups21,23,24 have
shown controversial results after implanting Cht-based ma-
terials. An adverse inflammatory response showing exten-
sive MØ activation after subcutaneous implantation of either
lyophilized chitosan21 or collagen–chitosan–hydroxyapatite
hydrogels in rats23 was detected. Conversely, other authors
showed that chitosan hydrogels induce mild acute and
chronic inflammatory responses, identical to the typical
wound-healing cascade, after subcutaneous25 and intraperi-
toneal (IP) implantations in rats.24
Nevertheless, the significance of chitosan within the bio-
medical field is unquestionable since the observed differences
on the response of cells and tissues to the different chitosan-
based materials may be attributed or influenced by the source
of the rawmaterial or by the shape of the biomaterial. Chitosan
has also been one of the most used materials to improve the
biological performance of other materials such as metals26–29
and other biodegradable polymers.7,16,30 Recent studies dem-
onstrated that neonatal rat calvaria osteoblasts proliferate at
higher rates on titanium surfaces coated with chitosan,26
which also promote better adhesion of osteoblast-like cells.27
In the same way, the hydrophobic surface of poly(L-lactide)
matrices coated with chitosan displayed a different wettability
and enhanced cell affinity.28 In a rabbit tibia defect model,
Bumgardner and co-workers29 showed that the coating of ti-
tanium pins with chitosan induced minimal inflammatory
response and a typical healing sequence of fibrous woven
bone formation followed by the development of lamellar
bone. This is indicative for the role of the chitosan-coatings in
the osseointegration of orthopedic implants.29 When blended
with synthetic polymers, such as polycaprolactone16 or poly
(butylene succinate),30 chitosan have shown to exert a syner-
gistic effect of on the blend. While the synthetic polyester
promoted the adhesion of osteoblast-like cells, the presence of
chitosan significantly enhanced their osteoblastic activity.16,30
Chitosan/soy-based membranes (Cht/Soy-M) have also
demonstrated improved in vitro biological performance in
comparison to unblended soy-based materials.7 Additionally,
in vitro analysis of the potential of Cht/Soy-M to stimulate
immune system cells showed that they did not elicit the ac-
tivation of human PMNs freshly isolated from circulating
blood.31 Despite the in vitro promising results, in vivo valida-
tion of the improved biological behavior of the soy-based
materials after blended with Cht is needed, since the organism
includes a very complex immune system. Therefore, the aim
of this study was to test the influence of chitosan in the host
response provoked by soy-based biomaterials. The response
to the rawmaterials soybean protein isolate powder (SI-P) and
chitosan powder (Cht-P) was assessed after injection in the
intraperitoneal cavity of rats. The in vivo reaction to soybean
protein isolate membrane (SI-M) and Cht/Soy-M was com-
pared after subcutaneous implantation of the biomaterials.
The results from the different models and the comparison of
the performance of the SI- and the chitosan-blended mem-
branes allowed to conclude about the effect of the chitosan
over the in vivo behavior of soy-based membranes.
Materials and Methods
Materials
The tested materials were (1) SI-P, (2) Cht-P, (3) SI-M and
(4) Cht/Soy-M. SI was provided by Loders Crocklaan BV
(The Netherlands) and the reagent-grade Cht, with a dea-
cetylation degree of 85% and viscosimetric molecular weight
of about 700KDa, by Sigma. Before the experiments, Cht was
purified by re-precipitation method.32 The SI-Ms were pre-
pared by solvent casting, according to a previously reported
procedure.33 Briefly, SI was suspended in distilled water
(10%, w/v) at room temperature under gentle stirring to
avoid protein denaturation and, consequently, foam forma-
tion. Glycerol was added to this suspension (1 g per 5 g of SI),
which was then poured into molds, directly in the drying
place. The molds were not moved until complete drying
to assure that the insoluble part of SI was uniformly dis-
tributed. Drying was performed at room temperature and
relative humidity. Alternatively, denatured SI membranes
(dSI-M) were prepared by heating the referred SI suspen-
sions at 1008C during 2 h. After denaturation, the obtained
viscous solution was cast as described above. Cht/Soy-M
were produced by solvent casting method.8 A 4wt% Cht
solution was prepared by dissolving Cht in a 0.2M acetic
acid solution. A 1wt% soy suspension (water/glycerol [10%,
w/v]) was also prepared and the pH adjusted to 8.0
0.3 with 1M sodium hydroxide solution. Previous reports
showed that the addition of glycerol can accelerate the
membrane formation process,34 while the alkaline conditions
help the soy film formation by adding protein dispersion in
film-forming solutions.35 The dispersion was heated in a
water bath at 508C for 30min. The blend was prepared by
means of mixing the solutions (75/25wt% chitosan–soy
protein) under constant agitation for 1 h. After the chitosan–
soy protein solutions had been homogenized, they were cast
into Petri dishes and dried at room temperature. To neu-
tralize the acetic acid, the dried membranes were immersed
in 0.1M sodium hydroxide for about 10min, and then
washed with distilled water to remove all traces of alkali,
followed by drying at room temperature.
Animals
Twenty-four male Wistar Han rats (Charles River)
weighting 420–450 g were used for the subcutaneous im-
plantation of SI-M and dSI-M, as well as for the IP injection
of SI-P and Cht-P. Four male Sprague-Dawley rats (Himberg
breeding Institute) weighting 320–470 g were used for the
subcutaneous implantation of the Cht/Soy-M. Animal ex-
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perimentation was performed according to the standard
operating procedures approved by the national authorities.
Intraperitoneal injection of SI-P and Cht-P
Phosphate-buffered saline (PBS; 0.01M; Sigma-Aldrich)
suspensions of the powders with different concentrations
(0.1% and 1% SI, and 0.1%, 1%, and 2% Cht) were injected
into the IP cavity of the rats (1mL per animal). Three animals
per concentration and per time period (16 h, 3 days, 7 days,
and 15 days) were used. One animal per each concentration
and per time period was injected with sterile PBS as control.
The animals had access to food and water ad libitum during
the entire observation period.
Subcutaneous implantation of membranes
I. Subcutaneous implantation of the SI-M. For the im-
plantation of the SI-M and the dSI-M, the Wistar Han rats
were anesthetized by an IP injection of 2.5% pentobarbital
(CEVA Sante´ Animale). The interscapular region was shaved
and disinfected with 70% ethanol, a full-thickness skin
longitudinal incision (about 1.5 cm) was performed in each
animal and one cranial-oriented subcutaneous pocket was
created by blunt dissection. A membrane (12mm diameter)
was positioned into each pocket and the incision was care-
fully sutured. Three animals were used per each time period
of implantation (3, 7, 15, and 30 days), and per type of
membrane. For each time period of implantation, a control
animal, with an empty subcutaneous pocket, was set. The
animals were kept in single cages with food and water
ad libitum during the whole experimentation period.
II. Subcutaneous implantation of the Cht/Soy-M. Male
Sprague-Dawley rats were anesthetized before surgery by
intramuscular injection of 90mg/kg ketamine hydrochloride
(Schoeller Chemie Produkte) and 5mg/kg xylazine hydro-
chloride (Bayer AG). For the subcutaneous implantation
of the Cht/Soy-M, two medial full-thickness skin incisions
were performed on the dorsum of the rats. Two craniolateral-
oriented pockets per each incision one to the left and one to
the right were subcutaneously created by blunt dissection,
and the membranes were inserted into these pockets (four
membranes/animal). The animals were kept in single cages
with food and water ad libitum during the whole experi-
mentation period.
Cytological preparations
The kinetics of the inflammatory reaction induced by the
injected suspensions (made from the powders) was assessed
by analysis of the peritoneal exudate. The animals were an-
esthetized with a subcutaneous injection of 2.5% pentobar-
bital and sacrificed with an intracardial overdose of
anesthetic. The abdominal area of each animal was disin-
fected with 70% ethanol, and an incision in the abdominal
skin and the linea alba was made to expose the external
abdominal wall as most as possible to the subsequent lavage.
Thirty-five milliliters of sterile PBS was injected into the IP
cavity, and the abdomen was massaged to recover the in-
flammatory cells adherent to the abdominal organs and
peritoneal cavity. The peritoneal exudate was collected in a
syringe and stored on ice until further analysis. The total
number of leukocytes was counted using a hemocytometer,
and cytospins of 1106 cells were performed by cytocen-
trifugation (5min at 1000 rpm). Cells were then gently wa-
shed in tap water and fixed in formaldehyde-ethanol (50/50
[v/v] formaldehyde 3.7% and absolute ethanol) for 45 s. The
Wright’s staining for blood samples (Hemacolor) was per-
formed, and after being dried, each slide was observed in an
optical microscope. A minimum of 300 cells per sample were
counted in different areas of the cytospin and the different
types of leukocytes distinguished.
Histological preparations
The animals with the implanted SI-M, dSI-M, and Cht/
Soy-M were anesthetized, at the end of each implantation
period, respectively, with an IP injection of 2.5% pentobar-
bital or with an intramuscular injection of 90mg/kg keta-
mine hydrochloride and 5mg/kg xylazine hydrochloride,
and sacrificed with an intracardial overdose of anesthetic.
The implanted membranes, the respective surrounding tis-
sue, and the lymph nodes of the rats with Cht/Soy-M were
explanted and prepared for histological analysis using he-
matoxylin and eosin staining and subsequently analyzed
using an Axioplan Imager Z1 microscope (Zeiss). In-
flammatory reaction, integration of the membranes in the
host tissue, and in vivo degradation were the assessed pa-
rameters.
Statistical analysis
Mean values and standard deviations are reported for the
measurements of the leukocyte kinetics. Data were analyzed
by a single-factor analysis of variance test and the signifi-
cance value was set at p< 0.05.
Results
Leukocyte recruitment kinetics
The IP injection of a suspension of SI-P allowed creating,
after counting the existing subpopulations, the kinetic of
leukocyte recruitment into in the IP cavity subsequent to its
injection.
The number of PMNs, expected to be the first recruited
cell type, was negligible in the negative control, showing that
the injection of the saline did not elicit a significant recruit-
ment of those cells. Few PMNs were found at 16 h after the
saline injection, which is expected as a normal reaction to the
injection.
Conversely, PMNs were extensively recruited early after
injection of the SI-P suspensions. The number of recruited
PMNs reached a peak 16 h postinjection of the 0.1% SI-P
suspension and decreased to values similar to the control
from that time point onward. After injection of the higher
concentration of SI-P (1%), higher numbers of PMNs were
detected up to 3 days while consecutively decreasing.
Concerning the number of PMNs after the injection of the
Cht suspensions, a recruitment pattern similar to the nega-
tive control was observed at all times. A higher, but not
statistically significant ( p> 0.05), number of PMNs was re-
cruited in the presence of the higher concentration of Cht-P
(2%) 16 h postinjection. This number decreased afterward to
comparable values to the observed for lower concentrations
of Cht-P and for the control.
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Macrophages (MØ), either tissue resident or recruited from
the bloodstream, are the most abundant cells in the IP cavity
at physiological conditions. Therefore, the constant number of
MØ observed for the control along the time was expected and
attributed to resident cells. Sixteen hours after the injection
of the SI-P, the number of detected MØ was higher than that
for the negative control (p< 0.05) and associated, together
with the PMNs reaction, to an expected inflammatory reac-
tion to any implantation procedure. MØ recruitment reached
a maximum between days 3 and 7 (p< 0.05), and between 7
and 14 days (p< 0.05), respectively for 0.1% and 1% of SI-P.
The number of MØs started to decrease from that day onward
although a significantly higher number, compared to the
negative control, was detected at day 15 for 1% SI-P.
Regarding the number of MØ present in the peritoneal
cavity of the animals injected with the three different con-
centrations of Cht-P, no significant differences ( p> 0.05)
were observed between them and in comparison to the
negative control at all time points.
In the context of a chronic inflammation, it is expected that
lymphocytes, the type of cells that correlate with the onset of
the reaction, would start to migrate from circulation around
day 7 after the inflammatory challenge. Nonetheless, lym-
phocytes are also resident cells in the peritoneal cavity. The
presence of lymphocytes was in fact noticed in the negative
control at earlier time points. An increase (p< 0.05) in the
number of lymphocytes was observed after the injection of the
SI-P. The percentage of SI-P and the time of reaction did not
induce significant changes over the recruitment kinetics except
for 0.1% SI-P at day 3 that presented a value significantly
different from the control. As for the PMNs and MØ, the
number of recruited lymphocytes to the peritoneal cavity in the
animals injected with the three different concentrations of Cht-
P was comparable to the negative control at all time points.
The recruitment of eosinophils and mast cells, which are
mostly related with allergic reactions, was negligible after the
injection of the saline (negative control). The same profile
was observed for all of the concentrations of Cht-P and SI-P
during the observation time. An exception was detected for
the 0.1% SI-P solution, which induced a maximum of eo-
sinophil and mast cell exudation at day 3, although the in-
crease was not statistically significant ( p> 0.05). From that
time period onward the number of these cells decreased,
reaching levels comparable to the other tested concentration
and the negative control.
Histological analysis
I. SI-M and dSI-M degradation and tissue inflammatory
response. Animals did not show any surgical complications
during the postoperative period. The explantation of SI-M,
dSI-M, and the respective surrounding tissue was performed
at 3, 7, 14, and 30 days after the subcutaneous implantation
and processed for histological analysis. Inflammatory reac-
tion, integration of the membranes in the host tissue, and
in vivo degradation were the assessed parameters.
The obtained histological sections revealed that, after 3 days
of implantation, the SI-M maintained its integrity (Fig. 1A, B)
compared to the dSI-M (Fig. 1C, D), which lost some of its
integrity. Additionally, the extension of the observed inflam-
matory infiltrate was higher in the dSI-M (Fig. 1C, D) than in
the SI-M (Fig. 1A, B), demonstrating that the dSI-M elicited
higher recruitment of inflammatory cells in comparison to the
SI-M. The histological examination at day 3 of implantation
revealed the physical separation between the membranes and
the adjacent tissue, resulting from the processing procedure.
However, it was possible to notice a more evident detachment
of the SI-M (Fig. 1A) from the inflammatory infiltrate in con-
trast to the dSI-M (Fig. 1C) in which attached inflammatory
cells were easily identified. A detailed observation of the his-
tological sections showed that the inflammatory infiltrate is
mainly constituted of PMNs, characterized by multilobulated
nuclei, recruited from circulation in response to either the SI-M
(Fig. 1B) or the dSI-M (Fig. 1D). Nonetheless, some mononu-
clear cells, presenting a smaller cytoplasm and a round shaped
nucleus, were also observed in both situations.
FIG. 1. Microscopic images obtained from the explanted SI-M (A, B, E, F) and dSI-M (C, D, G, H) and surrounding tissue,
subcutaneously implanted for 3 (A, B, C, D) and 7 (E, F, G, H) days in rats. It is possible to observe the membrane (M)
surrounded by inflammatory infiltrate (II). SI-M, soybean protein isolate membrane; dSI-M, denatured SI-M. Color images
available online at www.liebertonline.com/ten.
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After 7 days of the subcutaneous implantation of the SI-M
and the dSI-M, the density of the inflammatory infiltrate
increased (Fig. 1E, G). The degradation of both types of
membranes was obvious after 7 days of implantation (Fig.
1E–H), although more noticeable, like at 3 days of implan-
tation, for the dSI-M. Moreover, a network of fibrotic tissue
was observable surrounding the inflammatory infiltrate,
again characterized by the presence of PMNs, which seem to
be attempting to phagocyte the polymeric material, and
mononuclear cells. In the tissue surrounding the dSI-M, the
inflammatory infiltrate was denser, and early signs of edema
formation and necrosis with the exteriorization of cell cyto-
plasm, and the presence of cell debris and picnotic nucleus
were clearly identified (Fig. 1H).
After 14 days of implantation, the expected resolution of a
normal inflammatory process was not occurring. In the case
of the SI-M, the PMNs persisted (Fig. 2A, B). Additionally,
cell apoptosis and necrosis are evident (Fig. 2B) and seem to
increase in comparison to 7 days of implantation. These
observations were even more evident for the dSI-M; the
density of the inflammatory infiltrate was higher and the
signs of necrosis were even clearer (Fig. 2C, D). At this stage,
the degradation of the dSI-M was also more pronounced,
compared to both the SI-M and the first 7 days of implan-
tation of the dSI-M.
After 30 days of subcutaneous implantation of the SI-M
and dSI-M, the degradation of the membranes, the edema,
and necrosis evidently increased more compared with the
previous implantation periods (Fig. 2E–H).
II. Cht/Soy-M degradation and tissue inflammatory re-
sponse. The Cht/Soy-Ms were subcutaneously implanted
in rats for 7 and 14 days. During the postimplantation period
no signals of systemic or regional surgical complications
were detected for any of the animals. The local and systemic
host responses to the implanted materials were analyzed
after histological processing of the explants comprising the
implanted Cht/Soy-M and respective surrounding tissue,
and of the axillary and inguinal lymph nodes.
Local reaction to the Cht/Soy-M after 7 days of implantation
comprised an inflammatory infiltrate formed by recruited
PMNs (Fig. 3A). Additionally, some matrix started to be de-
posited around resident and inflammatory cells present in the
subcutaneous tissue. Further, blood vessels and adipocytes
were also observed in the surroundings of the implantation site
(Fig. 3B). Concerning the systemic host response, the analysis
of the neighboring lymph nodes revealed its reactive state
characterized by a higher cell density of the germinal centers
compared to the medullar region (Fig. 3C). Additionally, no
material debris was observed into the lymph nodes (Fig. 3C).
After 14 days of implantation, the progress of the in-
flammatory reaction was noticed; the inflammatory infiltrate
was concentrated a few microns from the membrane, and the
newly developed vascularization of connective tissue was
evident (Fig. 3D, E). The presence of mononuclear cells that
typically appear 2 weeks after the implantation of the ma-
terial, and the absence of persistent PMNs were detected.
Moreover, foreign body giant cells, one of the typical features
of chronic inflammation, were not observed at the material–
tissue interface (Fig. 3E). Similar to what was observed for
day 7 of implantation, the neighboring lymph nodes showed
comparable signs of reactivity (Fig. 3F).
Discussion
The combination of one of the most used natural materi-
als, Cht,6,13,14,36 with a rather promising one, soy,5,37 has
recently been shown to possess very interesting features7,8,31,33
that should be explored within the context of potential bio-
medical applications. Following these recent findings and
considering that there is a significant number of reports in the
literature that highlight soy’s inflammatory and allergic
character,11,38 the evaluation of the in vivo behavior of those
materials was missing. Therefore, this study aimed to inves-
tigate the in vivo host reaction of these materials.
One of the most relevant features of biodegradable bio-
materials that determine a successful performance refers to
its degradation rate and subsequent degradation products.
FIG. 2. Microscopic images obtained from the explanted SI-M (A, B, E, F) and dSI-M (C, D, G, H) and surrounding tissue,
subcutaneously implanted for 14 (A, B, C, D) and 30 (E, F, G, H) days in rats. At these time points, there is a denser
inflammatory infiltrate (II) surrounding the membrane (M), and some necrosis (N) and edema (O) is observed. Color images
available online at www.liebertonline.com/ten.
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The direct reaction to these as well as the inability of the host
to deal with those products has been frequently reported as
the major cause of implant failure.39 Thus, the testing of Cht
and soy materials was considered relevant for a first as-
sessment of the inflammatory and allergic potential of the
materials in study. The host tissue response to both Cht and
soy suspensions was monitored by investigating the IP leu-
kocyte kinetics at four different periods (3, 7, 14, and 30
days). The basal level of reaction, induced by the procedure,
was established with the injection of a saline and showed the
typical population of inflammatory cells present in the rat
peritoneal cavity in a physiological condition of minor
trauma due to injection.40 MØs, the IP-tissue-resident cells,
were the most evident type of cells detected. Although not at
significant numbers, lymphocytes can also be present in the
tissues,41 which justify the obtained values for the control.
Concerning leukocyte recruitment by the injection of SI
and Cht as suspensions from the powders into the IP cavity
of rats, SI-P elicited the recruitment of higher cell numbers
compared to Cht-P at all times studied. In this sense, SI-P
was considered more reactive to the host comparing to the
Cht-P, which, independently of the concentration, elicited
leukocyte recruitment comparable to the negative control.
Although it would be expected that a direct effect exists that
increasing the concentration of the suspension results in an
increase in the intensity of the provoked reaction, this was
not observed for the Cht-P, which is in agreement with
previous studies with Cht-based materials, showing a typical
inflammatory reaction induced by its implantation.42
The observed host response also did not seem to directly
correlate with the different concentrations of the tested SI-P.
SI induced a persistent recruitment of all inflammatory cell
types in comparison with the Cht-P and negative control,
since mononuclear cells (MØ and lymphocytes), the hall-
mark of a chronic inflammation, were extensively present at
the latter stage of the reaction (14 days). These results seem
to be in accordance with the observed reaction after the
subcutaneous implantation of the membranes. Despite the
absence of physiologic signs of inflammation or infection,
the histological analysis of the explants revealed a severe
host inflammatory reaction. Comparing the SI-M and the
dSI-M, it was observed that the reaction to dSI-M was more
intense. The extension of the inflammatory infiltrate was
representative of an acute persistent reaction characterized
by the presence of PMNs at longer implantation periods (14
and 30 days) that undergo frustrated phagocytosis. The
higher degradation rate of the dSI-M, in comparison to SI-M
and subsequent presence of smaller fragments of the mem-
brane, might be responsible for the stronger reaction since a
higher surface area is available for PMNs to respond to. The
metabolites secreted by the PMNs in this situation lead to the
decrease in the physiological pH and to the apoptosis and
necrosis of neighboring cells, evident at later stages of im-
plantation. Other studies43–45 suggested that surface prop-
erties such as hydrophilicity and surface charge determine
inflammatory cells apoptosis and necrosis. Nevertheless, a
typical foreign body reaction characterized by the presence
of foreign body giant cells able to phagocytize large material
debris (>10 mm)46 was not observed. This seems to indicate
that the degradation products of the implanted material are
either <10mm and thus phagocytozed by MØ, or metaboli-
cally re-absorbed by the host. These findings, showing the
absence of foreign body giant cells in the host tissue after the
implantation of Cht/Soy-M, are not typical for biodegrad-
able polymeric materials whose degradation products lead to
MØ fusion and fibrous tissue formation.47
The results of the leukocyte kinetics, where the SI-P in-
duced a severe and persistent recruitment of inflammatory
cells in the IP cavity of the rats after injection, were indicative
of the expected subcutaneous response and could be ex-
FIG. 3. Microscopic images obtained from the explanted Cht/soy-based membranes and surrounding tissue, subcutane-
ously implanted for 7 (A, B) and 14 days (D, E) in rats, as well as the nearby LN (C, F). Solid arrows (—") indicate inflammatory
cells; broken arrows (---"), blood vessels; arrowheads: collagen fibers. M, membrane; AT, adipose tissue; CT, connective tissue;
GC, germinal center; MR, medullar region; Cht, chitosan; LN, lymph nodes. The inserts in figures C and F represent higher
magnification images of the medular region and germinal centers. Color images available online at www.liebertonline.com/ten.
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trapolated from previous reports of inflammation caused by
soy products.11,38
The addition of Cht to the Soy-M improved, as expected,
the host response, which showed the features of a typical in-
flammatory response to implanted materials.19–21,24 Moreover,
the integration of the membranes within the surrounding tis-
sue was revealed by the presence of matrix39 after 2 weeks
of implantation. These results are in agreement with the re-
sults of other researchers, reporting the in vitro inhibition of
anti-inflammatory cytokines by Cht, such as interleukin-6,
interleukin-8, and tumor necrosis factor-a,48,49 which tend to
prolong the acute inflammatory response, instead of allowing
the host to progress to the resolution of inflammation.46 The
nonactivated state of the lymph nodes after Cht/Soy-M im-
plantation indicates that the implanted materials were not able
to induce a more systemic host reaction and no debris or
molecules of the materials were transported through circulation
to induce a remote response of the related lymphatic tissues.
The presented results assert the improvement of the host
response, considering inflammatory cells recruitment and
overall of the inflammatory reaction, when Cht is added to
soybean. In the context of previous indications on the be-
havior of PMNs after stimulation with Cht/Soy-M,31 the
present results may assert the influence of Cht on masking
specific soy reactive epitopes or even on suppressing leu-
kocyte activation, namely, PMNs. The Cht/Soy-M showed
the induction of a normal inflammatory reaction, and the
features characterizing this reaction are crucial for the inte-
gration of the implanted material, as well as for the ongo-
ing process of wound healing and tissue regeneration.
Together with previous results that reported their promis-
ing physicochemical characteristics and their inability to
activate human PMNs in vitro,31 the herein presented
conclusions reinforce the usefulness of the Cht/Soy-M and
justify the pursuit for a specific application within the bio-
medical field.
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